Figure 10

![Figure 10: Forest plot from meta-analysis of randomized controlled trials comparing EGb 761 at 240 mg/day with placebo using a random-effects model, quantifying the pooled effect on cognitive outcomes.]()

> Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." *Pharmaceuticals (Basel, Switzerland)*, 2021. PMID: [33915701](https://pubmed.ncbi.nlm.nih.gov/33915701/)

<figure>
  <img src="" alt="Forest plot from meta-analysis of randomized controlled trials comparing EGb 761 at 240 mg/day with placebo using a random-effects model, quantifying the pooled effect on cognitive outcomes." />
  <figcaption>Figure 10. Forest plot from meta-analysis of randomized controlled trials comparing EGb 761 at 240 mg/day with placebo using a random-effects model, quantifying the pooled effect on cognitive outcomes.<br>  Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33915701/">33915701</a></figcaption>
</figure>